| ANEBULO PHARMACEUTICALS |
| USA |
| Gesundheit |
| US0345691036 / A3CM1D |
| 214 (Frankfurt) / ANEB (NASDAQ) |
| FRA:214, ETR:214, 214:GR, NASDAQ:ANEB |
| - |
| https://www.anebulo.com/ |
|
Anebulo Pharmaceuticals Inc. is a biopharmaceutica..
>Volltext.. |
| 77.53 Mio. EUR |
| 68.7 Mio. EUR |
| - |
| -7.75 Mio. EUR |
| -7.21 Mio. EUR |
| -0.2 EUR |
| - |
| 8.84 Mio. EUR |
| -5.07 Mio. EUR |
| 10.74 |
| - |
| -1.12% |
| - |
| - |
| - |
| - |
| ANEBULO |
| 22.12.25 |
|
||||
|